Abstract: Drug utilization plays a role in helping the health care system to understand, interpret and improve the drug use and continuous quality improvement. It plays an essential part of pharmaco- Epidemiological studies. 100 prescriptions from paediatric patients with established diagnosis of acute exacerbation of Bronchial asthma were assessed from the Department of Paediatrics and the data gathered was analysed using MS Excel. A prospective cross-sectional study was done to conduct this study. Majority of the prescriptions irrespective of severity, inhalation beta2 agonist (salbutamol) as a bronchodilator was used. Nebulisation route was given for managing the acute exacerbations followed by inhalation route and oral route. Beclomethasone was prescribed to the patients suffering for severe bronchial asthma. Montelukast and levocetirizine were used for the patients suffering from allergic causes of asthma. Most of them was prescribed combination therapy. Beta2 Agonist and Leukotriene Antagonists are the most commonly prescribed combination drugs for asthma. The most commonly prescribed anti-asthmatic Medications in combination therapy was inhaled salbutamol and oral Montelukast. Nebulisation was preferred route to tackle the acute exacerbation of asthmatic symptoms.
Keywords: Drug utilisation, beta2 agonist